The healthcare world is observing a remarkable shift in glucose treatment with the arrival of GLP-1 transdermal devices. These devices offer a seemingly more user-friendly alternative to shots of GLP-1 drugs, minimizing the need for daily needle sticks. The technology administers the drug directl